American Oncology Network- Warrants (20/09/2028) Profit Margin

American Oncology Network- Warrants (20/09/2028)'s profit margin stands at -0.44% as of December 2024. That compares with -0.73% in the prior-year period — up 40.7% year over year. That is below the sector sector average of 22.52%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

American Oncology Network- Warrants (20/09/2028) reported -0.44% in profit margin versus -0.73% a year earlier — a 40.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

American Oncology Network- Warrants (20/09/2028) sits lower the its sector benchmark (22.52%) with a profit margin of -0.44%. That is roughly 101.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -0.44% for American Oncology Network- Warrants (20/09/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how American Oncology Network- Warrants (20/09/2028)'s profit margin evolved across reporting periods, while the comparison chart places AONCW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.